By Matthew Jordan, Associate Professor of Media Studies, Pennsylvania State University

Since the start of the pandemic, the film industry has been in free fall. As deaths have continued to climb, so have studio losses, with crowded theaters – once a source of collective entertainment and escapism – now seen as petri dishes for the virus.

Familiar blockbuster franchises whose summer releases studios banked on to balance bleeding ledgers have been barred from shuttered theaters. The 25th James Bond film, “No Time to Die,” the mind-bending thriller “Tenet” by directer Christopher Nolan, Marvel Universe’s “Black Widow,” and the DC Extended Universe’s “Wonderwoman 1984” have all been delayed. The billions of dollars invested in producing and marketing these films alone are sums that could make or break the studios.

Desperate to survive, AMC – the biggest of the three mega-chains of theaters – and movie studio Universal recently agreed to cut the exclusive theatrical release time down from 90 to 17 days before films could be streamed. Huge opening releases have long been crucial for both theater chains and studios, so AMC giving up its biggest source of revenue for a small cut of Universal’s profits can be seen as a sign of desperation.

The motion picture industry has endured pandemics and the threat of home viewing before. But in each instance, the existing way of doing things was upended. During the current crisis, it seems that shifts in the industry that have been going on for some time are accelerating. While the movie theater will likely survive, moviegoers can expect a change in what they can see on the big screen.

The first time ‘flu bans’ upended the industry

Before World War I, the American motion picture industry was a loose collection of independent film producers, distributors and approximately 20,000 theater owners. In the fall of 1918, the industry was rocked by the emergence of the Spanish flu. As wave after wave of influenza deaths spread across the country, between 80% and 90% of theaters were closed off-and-on for months by public health decrees, described across the country as “flu bans.”

Theaters that needed ticket sales to recoup advanced rental fees fought to stay open using strategies that are eerily familiar to our COVID-19 moment. Industry leaders lobbied governments to let them reopen. Theater owners denounced “flu hysteria” and handed out gauze masks to patrons. Some ejected sneezers or used staggered seating to socially distance audiences. The industry ran national public relations campaigns promoting hygiene and promising theater cleanings and new ventilation systems to help calm patrons’ fear of sitting shoulder-to-shoulder with someone who might cough. Even after “flu bans” were lifted, it took about a year and a half for skittish audiences to venture back.

As the pandemic ravaged the country, consolidation fever consumed the industry. Opportunists took advantage of the real victims of the flu bans: independent theaters. The big chains, armed with capital, bought out their hobbled competitors, while bigger distribution companies gobbled up smaller ones.

A new Hollywood studio system dominated by money and profits slowly started to take shape. Trailblazer Adolph Zukor used Wall Street financing to take control of the reeling Famous Players-Lasky company and merged it with Paramount distribution, creating a studio that cranked out films with Ford-like efficiency. With its soaring profits, it continued turning independent theaters into exclusive Paramount exhibitors across the country to monopolize access to audiences.

Others companies followed suit. Loews theaters, Metro pictures and Goldwyn distribution consolidated into MGM. Industry players desperate to recoup their pandemic losses traded their independence to be a part of the post-pandemic Hollywood, an oligopoly of vertically integrated companies that only distributed and screened the films they produced. Audiences previously comfortable watching all variety of shorts quickly developed a taste for the studio system’s expensive, feature-length, formulaic films.

TV threatens the oligopoly

In the 1950s, Hollywood faced a second destructive event of the 21st century: television, a new technology that could broadcast content directly into American homes. On the television, the motion picture form shifted from standard, feature-length films to serialized content similar to what people listened to on the radio.

The studio system felt the crunch. People who once went out to the movies multiple times a week now stayed home to watch TV. By 1954, there were 233 commercial stations and 26 million homes with TVs, and studio profits dramatically declined.

Yet Hollywood was able to adapt. The industry responded to the small screen home viewing threat by going big. Aspect ratios jumped from 1.34:1 to a wider 1.85:1 or 2.25:1, and they added Technicolor and high-fidelity directional audio to their sensational features.

Big budget epics like MGM’s “Quo Vadis,” musicals like 20th Century Fox’s “Annie Get Your Gun” and animated spectacles like Disney’s “Lady and the Tramp” ensured that theaters could provide an unrivaled experience, one that made watching TV seemed paltry by comparison. In the end, home viewing and theatrical release managed to coexist.

The worst of times, the best of times

In many ways, the current pandemic has been a tale of two movie industries. With theaters closed, streaming services have been cashing in. Netflix, which has been laying the grounds for a direct-to-streaming world since 2015, has added a whopping 10.1 million subscribers since March.

Alarmed by the billions of dollars stuck in pandemic purgatory, some studios have started to change tacks. Tom Hank’s new submarine film, “Greyhound,” steered its US$50 million budget directly to port on Apple TV+. Apple let financial markets know that the flim’s opening, in terms of the number of people who watched, rivaled the best opening weekends. Thirty percent of those viewers were new subscribers.

Seen in this light, the AMC and Universal deal shows the old distribution model, already battered by streaming services, taking on water fast. Yet rather than being extinguished, the theater model will likely continue to evolve. There is simply too much potential for return on investment in past, present and future blockbusters, and studios see the risk-reward ratio of theatrical release as a way to attract shareholders and keep them happy.

Audiences will still go out to be thrilled by big, CGI-driven spectacles with gut-rumbling surround sound. They’ve got a taste for it. At the same time, major studios will likely continue to use their economic leverage to push into streaming in an attempt to maximize their potential for profit and control both modes of distribution.

It is also possible that – with the winds of antitrust sentiment starting to blow – the industry will return to a theatrical distribution model more akin to the pre-Spanish Flu era, when independent theaters could make deals with different distributors to show more than just blockbusters, and use this flexibility to cultivate new or niche audiences.

If the lessons of the post-pandemic 1920s prove prophetic, we could be gearing up for a roaring decade where a rich diversity of films – in form, style and content – emerge to fit different modes of distribution. Think new series formats, or even mini “character universes” that rival Marvel’s on the small screen. Seen this way, the 2020s could be a glorious period of experimentation and innovation.

Support evidence-based journalism with a tax-deductible donation today, make a contribution to The Conversation.

The Milwaukee Independent began reporting on what was then referred to as the mysterious “Wuhan Virus” in January 2020. Other local media did not picked-up on the story until many weeks later. Our early features focused on the economic impact, social issues, and health concerns long before other Milwaukee news organizations even mentioned the coronavirus. Over the following year, we have published hundreds of articles about the pandemic and how it has affected the lives of Milwaukee residents. This extensive body of work can be found on our COVID-19 Special Report page, a chronological index of links by month. Our editorial voice remains dedicated to informing the public about this health crisis for as long as it persists.
For medical resources, please visit the CDC’s COVID-19 page or the Wisconsin Department of Health Services. All editorial content published by Milwaukee Independent can be found at mkeind.com/COVID19. With a mission of transformative journalism, our staff is free from commercial bias and are not influenced by corporate interests, political affiliations, or a public preferences that rewards clicks with revenue. As an influential publication that provides Milwaukee with quality journalism, our award-winning photojournalism and features have helped to achieve a range of positive social impact that enriches our community. Please join our effort by entrusting us with your contribution. Your Support Matters - Donate Now